SK bioscience has begun human testing of GBP551, the first multi-coronavirus vaccine, built on University of Washington nanoparticle technology. The Phase 1 trial aims to generate broad immunity against multiple coronaviruses, potentially transforming pandemic preparedness worldwide.
A Vaccine for All Coronaviruses: Inside the Ambitious Human Trial That Could Redefine Pandemic Preparedness
